1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
(
- Contribution to journal › Article
- 2020
-
Mark
Integrative pathway enrichment analysis of multivariate omics data
(
- Contribution to journal › Article
- 2018
-
Mark
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
(
- Contribution to journal › Article
- 2017
-
Mark
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
(
- Contribution to journal › Article
- 2015
-
Mark
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Mitochondrial D-loop and cytochrome oxidase C subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India
(
- Contribution to journal › Article
- 2000
-
Mark
Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer
(
- Contribution to journal › Article